TREA

79358602 - OMBLASTYS (131 I-OMBURTAMAB-YCWD)

Follow

Information

  • Trademark
  • 79358602
  • Serial Number
    79358602
  • Registration Number
    7341739
  • Filing Date
    October 17, 2022
    2 years ago
  • Registration Date
    April 02, 2024
    9 months ago
  • Transaction Date
    November 09, 2024
    a month ago
  • Status Date
    April 02, 2024
    9 months ago
  • Published for Opposition Date
    January 16, 2024
    11 months ago
  • Location Date
    April 02, 2024
    9 months ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    O'BRIEN, JENNIFER
  • Attorney Docket Number
    26691
    Attorney Name
    Andrew N. Spivak
    Law Office Assigned Location Code
    N30
  • Owners
Information
Mark Drawing Code
3
Mark Identification
OMBLASTYS (131 I-OMBURTAMAB-YCWD)
Case File Statements
  • DM0000: The mark consists of the wording "OMBLASTYS" and "(131 I-OMBURTAMAB-YCWD)". The word "OMBLASTYS" is in turquoise and appears in the middle of the figure mark. Below the word "OMBLASTYS" appears the second-word element "(131 I-OMBURTAMAB-YCWD)" in gray. In the top right corner of the mark just above "YS" in the word element "OMBLASTYS" a figure element appears. The shape element consists of three rhombuses right after each other at the top, where the first is in dark blue, and the one next to it is in dark green, and the next one next to it is in light green. Below these appear 5 triangles, the first, third and fifth are the same size, and the second and fourth are the same size but appear smaller than the first, third and fifth. The first triangle is in dark blue, and the second is also in dark blue. The third triangle is in the middle is turquoise. The penultimate fourth triangle is dark green. The last triangle is in green. The color white represents background, outlining, shading and/or transparent areas and are not part of the mark.
  • GS0051: Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; all of the aforesaid containing monoclonal antibodies
  • PM0001: OMBLASTYS ONE THREE ONE I OMBURTAMAB YCWD; OMBLASTYS ONE HUNDRED THIRTY ONE I OMBURTAMAB YCWD
  • CC0000: The colors turquoise, gray, dark blue, dark green, light green and green are claimed as a feature of the mark.
  • DS0000: "131 I-OMBURTAMAB"
  • GS0421: Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of in the field of oncology, chemotherapy, and inflammatory diseases, namely antibodies; industrial analysis and research services in the field of chemistry, namely antibodies
Case File Event Statements
  • 12/23/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 12/28/2022 - 2 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 12/30/2022 - 2 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/3/2023 - 2 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 8/1/2023 - a year ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/10/2023 - a year ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/11/2023 - a year ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 8/31/2023 - a year ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 8/31/2023 - a year ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 9/18/2023 - a year ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 10/30/2023 - a year ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/30/2023 - a year ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/31/2023 - a year ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/8/2023 - a year ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 12/8/2023 - a year ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/8/2023 - a year ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/8/2023 - a year ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/9/2023 - a year ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/27/2023 - a year ago
    21 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/27/2023 - a year ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/27/2023 - a year ago
    20 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 1/13/2024 - 11 months ago
    22 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 1/16/2024 - 11 months ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/16/2024 - 11 months ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/2/2024 - 9 months ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/2/2024 - 9 months ago
    26 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 7/3/2024 - 6 months ago
    27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 10/17/2024 - 2 months ago
    29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 10/17/2024 - 2 months ago
    28 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 11/9/2024 - a month ago
    30 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO